1/45
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
most drugs are made to be lipophilic
so they can cross the membranes
downside of being lipophilic
stays in body for a long time but we want to drug to do its job and then be excreted
solution to get rid of lipophilic drugs in body
body (and enzymes) has the ability to metabolize or biotransform the lipophilic structure to hydrophilic structure
2 categories of enzymes that biotransform
phase I
phase II
purpose of metabolism/biotransformation
decrease lipid solubility and increase ionization (make it more water soluble) to increase body excretion
phase 1
different enzymes that add or expose oxygen to make it more water soluble
phase I reaction
oxidation hydrolysis
cytochrome P450
enzyme family that biotransforms by oxidation hydrolysis, it adds a oxygen to a bond causing it to be more water soluble
-phase i
esterase hydrolysis
enzyme that biotransforms exposing an oxygen by breaking ester bonds to make two molecules with OH groups, makes it more water soluble
--phase i

amidase hydrolysis
enzyme that biotransforms by breaking amide bonds and breaks the bond to expose the oxygen to form OH → more water soluble
phase i

phase II
conjugation where different groups of enzymes add conjugates/groups/structures that are more water soluble
phase II reactions
glucuronidation, sulfation, methylation, acetylation, amino acid addition, and glutathione
glucuronidation enzyme (glucuronal transferase)
transfers glucuronide molecule on the drug to make it more water soluble
phase II
drugs can go thru
either phase I or phase II or both in any order
requirement for phase II
drug must have some functional group to act on (-OH, -SH, NH, -COOH)
drugs can become toxic
some enzymes from phase I or phase II reactions can make a drug toxic
drugs can be biotransformed into
active drugs, and/or into toxic metabolites
benzene
doesn’t have a functional group to be able to undergo phase II reactions
xenobiotics
substances absorbed across the lungs or skin
chemical substance found within an organism that is not naturally produced or expected to be there
mammalian drug biotransformation systems evolved from
the need to detoxify and eliminate plant and bacterial bioproducts and toxins, which later extended to drugs and other environmental xenobiotics
Renal excretion
plays a pivotal role in terminating the biologic activity of some drugs
lipophilic xenobiotics
are transformed to more polar and hence more readily excreted products
some biotransformation products
have enhanced activity or toxic properties
Phase I reactions usually convert
the parent drug to a more polar metabolite by introducing or unmasking a functional group
phase I metabolites
if sufficiently polar, they can be readily excreted but many products are not eliminated rapidly and undergo a reaction with a endogenous substrate like sulfuric acid to form a highly soluble polar conjugate (phase II)
sometimes phase I product
isn’t water soluble enough to be eliminated efficiently so it goes onto phase II where it adds a very polar group (conjugation)
-phase I does not always have to go first
After oral administration
many drugs are absorbed intact from the small intestine and transported first via the portal system to the liver, where they undergo extensive metabolism
-first-pass effect
First-pass effect
metabolism of an orally administered drug before it reaches systemic circulation, primarily involving the intestinal wall and liver
Bioavailability (F)
the fraction of the administered drug that reaches systemic circulation unchanged
Extensive first-pass metabolism
much of an oral drug is metabolized in the intestine/liver before reaching systemic circulation, resulting in low oral bioavailability
so another route is needed so the drug work its effect
Gut microorganisms
contain enzymes that can metabolize (biotransform) drugs and their metabolites in the lower GI tract
Gastric acid in stomach
Some drugs are chemically unstable in acid, so stomach acid can break them down
ex penicillin
Digestive enzymes in GI tract
designed to break down nutrients such as proteins, so if the drug is a peptide/protein, those enzymes may recognize it as something to digest
ex insulin
Enzymes in the intestinal wall
intestinal cells contain drug-metabolizing enzymes
two ways a drug can be chemically changed
Spontaneously - no enzyme needed
Enzyme-catalyzed - more common
microsomes
the small pieced endoplasmic reticulum (ER) are broken into
rough microsomes
protein synthesis
smooth microsomes
rich in enzymes responsible for oxidative drug metabolism aka mixed function oxidases (MFOs), or monooxygenases which require a reducing agent NADPH
how CYP450 actually performs Phase I oxidation
requires NADPH + O₂. NADPH transfers electrons through CPR (using FAD and FMN) to CYP450. CYP450 uses those electrons and O₂ to oxidize the drug: one oxygen enters the drug and the other forms H₂O
Microsomal drug oxidations require
P450, P450 reductase, NADPH, and molecular oxygen
CYP3A4 alone
responsible for the metabolism of over 50% of the prescription drugs metabolized by the liver
P450 enzymes (CYP)
large family of enzymes that metabolize drugs and other chemicals, especially in the liver
P450 enzymes can be induced
by substrate stabilization which is decreased degradation
suicide inhibitors
drugs/chemicals that an enzyme starts to metabolize, but during that process the chemical turns into something that permanently inactivates the enzyme itself
Phase II reactions are relatively faster than
P450-catalyzed reactions